B. Gerber

发表

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

P. Fasching, C. Denkert, W. Eiermann, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Gideon Blumenthal, Nina Ditsch, David Cameron, 2014, The Lancet.

A pooled analysis of bone marrow micrometastasis in breast cancer.

T. Fehm, R. Coombes, A. Vincent-Salomon, 2005, The New England journal of medicine.

Sorafenib (SOR) plus docetaxel (DOC) as first-line therapy in patients with HER2-negative metastatic breast cancer (MBC): A randomized, placebo-controlled phase II trial.

M. Beckmann, A. Schneeweiss, F. Marmé, 2014 .

Simple ovarian cysts in premenopausal patients

T. Reimer, B. Gerber, H. Müller, 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

The Oncological Safety of Skin Sparing Mastectomy with Conservation of the Nipple-Areola Complex and Autologous Reconstruction: An Extended Follow-Up Study

G. Kundt, T. Reimer, B. Gerber, 2009, Annals of surgery.

Mastectomy - Current Challenges and Questions

B. Gerber, 2017, Breast Care.

Breast Reconstruction Following Cancer Treatment.

M. Untch, B. Gerber, A. Faridi, 2015, Deutsches Arzteblatt international.

Implant-Based Breast Reconstruction Using a Titanium-Coated Polypropylene Mesh (TiLOOP Bra): A Multicenter Study of 231 Cases

J. Blohmer, S. Paepke, B. Gerber, 2013, Plastic and reconstructive surgery.

A short-term follow-up of implant based breast reconstruction using a titanium-coated polypropylene mesh (TiLoop(®) Bra).

T. Reimer, B. Gerber, H. Dieterich, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Using a titanium-coated polypropylene mesh (TiLOOP® Bra) for implant-based breast reconstruction: case report and histological analysis

T. Reimer, B. Gerber, H. Dieterich, 2012, Archives of Gynecology and Obstetrics.

Management of early invasive breast cancer in very young women (<35 years).

Bernd Gerber, T. Reimer, B. Gerber, 2011, Clinical breast cancer.

Patient Selection and Technical Considerations in Nipple-Sparing and Areola-Sparing Mastectomy

B. Gerber, M. Dieterich, 2011 .

[Skin sparing mastectomy with autologous immediate reconstruction: oncological risks and aesthetic results].

T. Reimer, K. Friese, B. Gerber, 2000, Zentralblatt fur Gynakologie.

Skin-Sparing Mastectomy with Conservation of the Nipple–Areola Complex and Autologous Reconstruction is an Oncologically Safe Procedure

G. Kundt, T. Reimer, K. Friese, 2003, Annals of surgery.

Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.

T. Reimer, B. Gerber, M. Freund, 2010, Deutsches Arzteblatt international.

Abstract S3-1: Lapatinib vs Trastuzumab in Combination with Neoadjuvant Anthracycline-Taxane-Based Chemotherapy: Primary Efficacy Endpoint Analysis of the GEPARQUINTO STUDY (GBG 44)

M. Rezai, P. Fasching, R. Kreienberg, 2010 .

Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer

T. Reimer, K. Friese, H. Thiesen, 2002, Breast Cancer Research.

Effects o f A djuvant T amoxifen o n t he E ndometrium i n Postmenopausal W omen W ith B reast C ancer: A P rospective Long-Term S tudy U sing T ransvaginal U ltrasound

T. Reimer, K. Friese, B. Gerber, 2000 .

Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.

T. Reimer, K. Friese, B. Gerber, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

P. Fasching, T. Fehm, C. Denkert, 2020, Clinical Cancer Research.

Central review of radiation therapy planning among patients with breast-conserving surgery: results from a quality assurance process integrated into the INSEMA trial.

T. Kühn, S. Loibl, V. Nekljudova, 2020, International journal of radiation oncology, biology, physics.

Correlation of various pathologic complete response (pCR) definitions with long-term outcome and the prognostic value of pCR in various breast cancer subtypes: Results from the German neoadjuvant meta-analysis.

P. Fasching, W. Eiermann, S. Loibl, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.

M. Rezai, T. Fehm, S. Loibl, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Controversies in preservation of ovary function and fertility in patients with breast cancer

T. Reimer, B. Gerber, H. Müller, 2008, Breast Cancer Research and Treatment.

Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding.

G. Kundt, T. Reimer, K. Friese, 2001, European journal of cancer.

Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto.

M. Rezai, P. Fasching, A. Schneeweiss, 2014 .

Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study.

W. Eiermann, S. Loibl, S. Kümmel, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Postoperative infections due to bladder catheters after anterior colporrhaphy: a prospective, randomized three-arm study

G. Kundt, T. Reimer, B. Gerber, 2010, International Urogynecology Journal.

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

M. Beckmann, P. Fasching, T. Fehm, 2015, Breast Care.

Impact of Multifocal or Multicentric Disease on Surgery and Locoregional, Distant and Overall Survival of 6,134 Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

M. Rezai, C. Denkert, T. Kühn, 2015, Annals of Surgical Oncology.

BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.

Tanja Fehm, Brigitte Rack, Chunling Hu, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto

M. Rezai, P. Fasching, A. Schneeweiss, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.

M. Rezai, T. Fehm, T. Kühn, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC) ± bevacizumab - results of the randomised GeparQuinto study (GBG 44).

M. Rezai, P. Fasching, H. Tesch, 2013, European journal of cancer.

Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus

P. Fasching, T. Fehm, A. Schneeweiss, 2015, Geburtshilfe und Frauenheilkunde.

Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.

G. Kundt, T. Reimer, W. Janni, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.

P. Fasching, F. Couch, K. Gelmon, 2021, European journal of cancer.

Nutrition and Lifestyle Factors on the Risk of Developing Breast Cancer

T. Reimer, K. Friese, B. Gerber, 2003, Breast Cancer Research and Treatment.

Expression pattern of progranulin in the human placenta and its effect on cell proliferation in the choriocarcinoma cell line BeWo.

B. Gerber, J. Stubert, V. Briese, 2011, The Journal of reproduction and development.

Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial

P. Fasching, A. Schneeweiss, C. Denkert, 2022, Cancers.

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

M. Lux, P. Fasching, T. Fehm, 2021, Geburtshilfe und Frauenheilkunde.

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021

M. Lux, P. Fasching, T. Fehm, 2021, Breast Care.

Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.

M. Rezai, C. Denkert, J. Heil, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of Ultrasound Features Predicting Axillary Nodal Metastasis in Breast Cancer: The Impact of Cortical Thickness

T. Reimer, B. Gerber, Ä. Glass, 2015, Ultrasound International Open.

Assessment of Ultrasound Features Predicting Axillary Nodal Metastasis in Breast Cancer: The Impact of Cortical Thickness.

T. Reimer, B. Gerber, Ä. Glass, 2015, Ultrasound international open.

13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)

M. Beckmann, T. Fehm, A. Schneeweiss, 2013, Breast Care.

Gallen-Konsensuskonferenz ( Wien 2017 ) Initial Treatment of Patients with Primary Breast Cancer : Evidence , Controversies , Consensus Spectrum of Opinion of German Specialists at the 15 th International St . Gallen Breast Cancer Conference ( Vienna 2017 )

P. Fasching, T. Fehm, A. Schneeweiss, 2017 .

Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017).

P. Fasching, T. Fehm, A. Schneeweiss, 2017, Geburtshilfe und Frauenheilkunde.

Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus Erstbehandlung von Patientinnen mit primärem Mammakarzinom: Evidenz, Kontroversen, Konsens

P. Fasching, T. Fehm, A. Schneeweiss, 2017, Geburtshilfe und Frauenheilkunde.

The Clinical Relevance of Target Lymph Node Biopsy after Primary Systemic Therapy in Initially Node-Positive Breast Cancer Patients

T. Reimer, B. Gerber, A. Stachs, 2021, Cancers.

Lost clips after targeted lymph node biopsy in breast cancer patients: Follow-up of the CLIP-study.

G. Kundt, T. Reimer, B. Gerber, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent Disease

M. Lux, C. Jackisch, W. Janni, 2018, Oncology Research and Treatment.

Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results.

T. Reimer, R. Fietkau, B. Gerber, 2008, International journal of radiation oncology, biology, physics.

Primary Metastatic Breast Cancer: The Impact of Locoregional Therapy

T. Reimer, B. Gerber, A. Stachs, 2014, Breast Care.

Transection of vaginal cuff is an independent prognostic factor in stage I endometrial cancer.

T. Reimer, R. Fietkau, B. Gerber, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Oncologic Outcome of Patients with (Low-Risk) Endometrial Carcinoma Undergoing Laparotomy versus Minimally Invasive Hysterectomy: A Retrospective Analysis

T. Reimer, B. Gerber, M. Dieterich, 2019, Oncology Research and Treatment.

Uterocervical angle as a predictor of preterm birth on a high‐risk collective between 20 and 31 weeks of gestation: A cohort analysis

B. Gerber, J. Stubert, Kathleen Gründler, 2020, Acta obstetricia et gynecologica Scandinavica.

Disseminated peritoneal leiomyomatosis (DPL): a case report

B. Gerber, R. Wiessner, A. Gehring, 2018, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow

N. Harbeck, S. Braun, H. Sommer, 2004, Breast Cancer Research and Treatment.

Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies Erhalt der Fertilität bzw. Ovarialfunktion beim Mammakarzinom sowie bei gynäkologischen und internistischen Malignomen

B. Gerber, A. Stachs, S. Hartmann, 2017, Geburtshilfe und Frauenheilkunde.

The Role of Hydroxyethyl Starch in Preventing Surgical-Site Infections and Nipple Necrosis in Patients Undergoing Reduction Mammaplasty: A Prospective Case–Control Study of 334 Patients

G. Kundt, T. Reimer, B. Gerber, 2013, Aesthetic Plastic Surgery.

Accuracy of immediate antepartum ultrasound estimated fetal weight and its impact on mode of delivery and outcome - a cohort analysis

B. Gerber, Ä. Glass, J. Stubert, 2018, BMC Pregnancy and Childbirth.

Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy.

P. Fasching, C. Denkert, H. Tesch, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Human chorionic gonadotrophin-beta transcripts correlate with progesterone receptor values in breast carcinomas.

T. Reimer, K. Friese, H. Thiesen, 2000, Journal of molecular endocrinology.

Adjuvant therapy for women over age 65 with breast cancer.

R. Souchon, B. Gerber, M. Sautter‐Bihl, 2011, Deutsches Arzteblatt international.

Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients.

B. Gerber, J. Makovitzky, V. Briese, 2007, Anticancer research.

Radiodiagnostics in the Follow-Up of Breast Cancer Patients

B. Gerber, M. Dieterich, 2007, Breast Care.

Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial.

T. Fehm, R. Kreienberg, S. Loibl, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

The Significance of Preoperative Computed Tomography for Predicting Optimal Cytoreduction in Advanced Ovarian Cancer

T. Reimer, B. Gerber, M. Dieterich, 2020, Geburtshilfe und Frauenheilkunde.

Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29).

M. Rezai, P. Fasching, A. Schneeweiss, 2016, European journal of cancer.

Port-site metastasis after diagnostic laparoscopy for presumably benign ruptured ovarian cyst: disseminated intraperitoneal metastasis of a Krukenberg tumor

K. Friese, E. Lochmüller, B. Gerber, 2004, Gynecological Surgery.

Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis

M. Glocker, T. Reimer, B. Gerber, 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Diagnosis of ruptured breast implants through high-resolution ultrasound combined with real-time elastography.

T. Reimer, B. Gerber, M. Dieterich, 2015, Aesthetic surgery journal.

Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy.

C. Denkert, M. Dietel, J. Budczies, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effectiveness of Trastuzumab (HerceptinTM) in a Patient with Locally Recurrent Breast Cancer after Cardiac Failure Caused by Severe Cytotoxic Pretreatment

T. Reimer, R. Fietkau, B. Gerber, 2001, Oncology.

Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study

M. Rezai, M. Beckmann, P. Fasching, 2015, International journal of cancer.

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

M. Lux, P. Fasching, T. Fehm, 2022, Breast Care.

Abstract S2-07: A randomized phase III trial comparing neoadjuvant chemotherapy with weekly nanoparticle-based paclitaxel with solvent-based paclitaxel followed by anthracyline/cyclophosphamide for patients with early breast cancer (GeparSepto); GBG 69

A. Schneeweiss, C. Denkert, S. Loibl, 2015 .

ZORO: A prospective randomized multicenter study to prevent chemotherapy-induced ovarian failure with the GnRH-agonist goserelin in young hormone-insensitive breast cancer patients receiving anthracycline containing (neo-) adjuvant chemotherapy (GBG 37).

S. Loibl, H. Sommer, B. Gerber, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS)

T. Reimer, B. Gerber, A. Stachs, 2022, Cancers.

Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials

A. Schneeweiss, C. Denkert, J. Heil, 2019, Annals of Surgical Oncology.

Oncoplastic breast-conserving surgery: More relevant than ever? Results of a survey among breast surgeons

M. Lux, D. Wallwiener, J. Heil, 2019, Archives of Gynecology and Obstetrics.

Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study.

A. Schneeweiss, F. Marmé, D. Strumberg, 2019, Breast.

NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto.

P. Fasching, A. Schneeweiss, C. Denkert, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA*

U. Fuhr, S. Loibl, N. Harbeck, 2014, Breast Care.

24 Zoledronic acid (ZOL) as add-on therapy in patients with tumour residuals after neoadjuvant chemotherapy for primary breast cancer – first interim safety analysis of the NATAN study (GBG 36)

H. Tesch, C. Jackisch, H. Eidtmann, 2010 .

11th International Conference St. Gallen: Primary Therapy of Early Breast Cancer

M. Beckmann, A. Schneeweiss, D. Wallwiener, 2009 .

Endocrine Treatment of Metastatic Breast Cancer

J. Huober, B. Gerber, 2006, Breast Care.

Epidermal growth factor receptor gene and c‐erbB‐2 gene amplification in ovarian cyst fluid

K. Luettich, T. Reimer, B. Gerber, 1996, Obstetrics and gynecology.

1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44)

M. Rezai, P. Fasching, T. Fehm, 2015 .

Primary prophylaxis with 3 weekly pegfilgrastim and ciprofloxacin effectively prevent (febrile) neutropenia and infection during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) in breast cancer patients

J. Blohmer, J. Huober, C. Jackisch, 2005 .

AGO Algorithms for the Treatment of Breast Cancer: Update 2021

P. Fasching, T. Fehm, A. Schneeweiss, 2021, Geburtshilfe und Frauenheilkunde.

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

M. Lux, P. Fasching, T. Fehm, 2021, Breast Care.

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial.

A. Schneeweiss, S. Loibl, G. von Minckwitz, 2010, European journal of cancer.

Concurrent Radiochemotherapy of Locally Recurrent or Advanced Sarcomas of the Uterus

T. Reimer, R. Fietkau, G. Klautke, 2006, Strahlentherapie und Onkologie.

Primary Malignant Vaginal Melanoma - Case Report and Review of the Literature.

B. Gerber, M. Dieterich, E. Klar, 2012, Geburtshilfe und Frauenheilkunde.

Goserelin versus CMF as adjuvant therapy for node-negative, hormone receptor-positive breast cancer in premenopausal patients. The GABG IV-A-93 trial.

W. Eiermann, W. Jonat, G. von Minckwitz, 2004, Journal of Clinical Oncology.

The safety of synthetic paclitaxel by intralesional delivery with OncoGel™ into skin breast cancer metastases: method and results of a clinical pilot trial

A. Schindler, M. Scheulen, B. Gerber, 2005, Archives of Gynecology and Obstetrics.

Reply to L. Del Mastro and Z. Blumenfeld

S. Loibl, B. Gerber, G. Minckwitz, 2011 .

Radiopaque tissue transfer and X-ray system versus standard specimen radiography for intraoperative margin assessment in breast-conserving surgery: randomized clinical trial

T. Reimer, B. Gerber, A. Stachs, 2022, BJS open.

S3-2: Neoadjuvant Chemotherapy Adapted by Interim Response Improves Overall Survival of Primary Breast Cancer Patients - Results of the GeparTrio Trial.

A. Schneeweiss, C. Denkert, W. Eiermann, 2011 .

Pathologic Nipple Discharge: Surgery Is Imperative in Postmenopausal Women

T. Reimer, B. Gerber, A. Krause, 2005, Annals of Surgical Oncology.

Concurrent Radiotherapy and Taxane Chemotherapy in Patients with Locoregional Recurrence of Breast Cancer

T. Reimer, R. Fietkau, G. Klautke, 2006, Strahlentherapie und Onkologie.

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022

M. Lux, P. Fasching, T. Fehm, 2020, Breast Care.

Preterm ETs Are Significantly Reduced Compared with Adults and Partially Reduced Compared with Term Infants

B. Gerber, J. Ruhnau, A. Vogelgesang, 2022, Children.

Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)

P. Fasching, C. Perou, J. Bergh, 2012 .

Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro).

M. Rezai, P. Fasching, A. Schneeweiss, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast reconstruction with latissimus dorsi flap: improved aesthetic results after transection of its humeral insertion.

T. Reimer, K. Friese, B. Gerber, 1999, Plastic and reconstructive surgery.

Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes.

T. Reimer, K. Friese, H. Thiesen, 2002, Molecular human reproduction.

Validation of a Nomogram Predicting Non-Sentinel Lymph Node Metastases among Patients with Breast Cancer after Primary Systemic Therapy - a transSENTINA Substudy

T. Fehm, C. Denkert, T. Kühn, 2018, Breast Care.

First international consensus conference on standardization of oncoplastic breast conserving surgery

P. Dubsky, F. Fitzal, N. Hauser, 2017, Breast Cancer Research and Treatment.

Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial.

T. Kühn, T. Reimer, B. Gerber, 2021, The British journal of surgery.

Recombinant human leukemia inhibitory factor is mitogenic for human bone-derived osteoblast-like cells.

D. B. Evans, B. Gerber, J. Feyen, 1994, Biochemical and biophysical research communications.

Local Treatment of the Axilla in Early Breast Cancer: Concepts from the National Surgical Adjuvant Breast and Bowel Project B-04 to the Planned Intergroup Sentinel Mamma Trial

T. Reimer, B. Gerber, A. Stachs, 2014, Breast Care.

Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors

T. Reimer, U. Jeschke, K. Friese, 2000, Histochemistry and Cell Biology.

Response-guided neoadjuvant chemotherapy for breast cancer.

Carsten Denkert, Andreas Schneeweiss, Stefan Paepke, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic and predictive impact of Ki-67 before and after neoadjuvant chemotherapy on PCR and survival: Results of the GeparTrio trial.

T. Fehm, C. Denkert, W. Eiermann, 2012 .

S5-4: pCR as a Surrogate in HER2−Positive Patients Treated with Trastuzumab.

P. Fasching, C. Denkert, S. Loibl, 2011 .

Ruptured Poly-Implant Protheses Breast Implant After Aesthetic Breast Augmentation: Diagnosis, Case Management, and Histologic Evaluation

T. Reimer, B. Gerber, M. Dieterich, 2013, Aesthetic Plastic Surgery.

Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer.

S. Loibl, B. Gerber, 2011, JAMA.

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy

T. Kühn, T. Reimer, Karin Dembrower, 2022, Breast Cancer Research and Treatment.

Abstract S3-1: Neoadjuvant Chemotherapy in the very young 35 years of age or younger

A. Schneeweiss, C. Denkert, S. Loibl, 2012 .

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

W. Weichert, K. Schlüns, C. Denkert, 2009, Breast Cancer Research.

Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.

S. Loibl, J. Unger, M. Ceppi, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

miRNA expression profiles determined in maternal sera of patients with HELLP syndrome

T. Reimer, H. Thiesen, D. Koczan, 2014, Hypertension in pregnancy.

Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review

T. Reimer, W. Janni, B. Gerber, 2006, Breast Cancer Research and Treatment.

Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy

B. Gerber, J. Siebert, V. Briese, 2011, Archives of Gynecology and Obstetrics.

Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue

Hans-Jürgen Thiesen, Johannes P C Vissers, Michael Hecker, 2009, Analytical and bioanalytical chemistry.

Inhibin/activin subunits (inhibin-α, -βA and -βB) are differentially expressed in human breast cancer and their metastasis

U. Jeschke, K. Friese, C. Kuhn, 2005 .

Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.

U. Jeschke, K. Friese, C. Kuhn, 2005, Oncology reports.

Invasive hydatidiform mole: immunohistochemical labelling of inhibin/activin subunits, Ki67, p53 and glycodelin A in a rare case.

K. Friese, B. Gerber, I. Mylonas, 2009, Acta histochemica.

Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

P. Fasching, W. Eiermann, S. Loibl, 2010, Breast Cancer Research and Treatment.

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Bingshu E. Chen, D. Berry, P. Fasching, 2019, The Lancet.

Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials

A. Schneeweiss, P. Neven, C. Denkert, 2015, Breast Cancer Research and Treatment.

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.

M. Rezai, P. Fasching, A. Schneeweiss, 2014, The Lancet. Oncology.

Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors.

T. Reimer, U. Jeschke, K. Friese, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy

Carsten Denkert, Keyur Mehta, Bernd Gerber, 2011, Breast Cancer Research and Treatment.

FasL:Fas ratio--a prognostic factor in breast carcinomas.

T. Reimer, K. Friese, H. Thiesen, 2000, Cancer research.

Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial

P. Fasching, A. Schneeweiss, C. Denkert, 2017, JAMA oncology.

Prediction of pathological complete response (pCR) by Homologous Recombination Deficiency (HRD) after carboplatin-containing neoadjuvant chemotherapy in patients with TNBC: Results from GeparSixto.

M. Rezai, P. Fasching, A. Schneeweiss, 2015 .

Immunohistochemically Detected Lymph‐Node Micrometastases in Breast Cancer and their Correlation with Prognostic Factors

T. Reimer, B. Gerber, A. Krause, 1997 .

Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.

T. Reimer, B. Gerber, M. Dieterich, 2014, Breast.

Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.

U. Jeschke, K. Friese, B. Gerber, 2005, Anticancer research.

Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis.

Hans-Jürgen Thiesen, Oliver Schmitt, Bernd Gerber, 2011, International journal of clinical and experimental pathology.

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.

A. Schneeweiss, C. Denkert, S. Loibl, 2016, The Lancet. Oncology.

Differential diagnosis of peri- and postmenopausal ovarian cysts.

T. Reimer, U. Jeschke, K. Friese, 1999, Maturitas.

Estradiol, gonadotropins, and tumor markers in ovarian cyst fluid

K. Luettich, T. Reimer, B. Gerber, 1997, Acta obstetricia et gynecologica Scandinavica.

Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.

U. Jeschke, K. Friese, W. Janni, 2005, Anticancer research.

Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.

U. Jeschke, K. Friese, B. Gerber, 2005, Archives of gynecology and obstetrics.

Expression of the inhibin/activin subunits alpha (α), beta-A (βA) and beta-B (βB) in benign human endometrial polyps and tamoxifen-associated polyps

U. Jeschke, K. Friese, B. Gerber, 2005, Archives of Gynecology and Obstetrics.

Fatal events during clinical trials: an evaluation of deaths during breast cancer studies

P. Fasching, A. Schneeweiss, S. Loibl, 2019, Breast Cancer.

Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

P. Fasching, T. Fehm, C. Denkert, 2013, Clinical Cancer Research.

Prevention of Early Menopause Study (POEMS): is it possible to preserve ovarian function by gonadotropin releasing hormone analogs (GnRHa)?

O. Ortmann, B. Gerber, B. Gerber, 2014, Archives of Gynecology and Obstetrics.

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial.

M. Rezai, P. Fasching, T. Kühn, 2012, The Lancet. Oncology.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

M. Lux, M. Beckmann, P. Fasching, 2018, Geburtshilfe und Frauenheilkunde.

Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)

A. Schneeweiss, C. Denkert, S. Loibl, 2017, Breast Cancer Research and Treatment.

Patient-Report Satisfaction and Health-Related Quality of Life in TiLOOP® Bra-Assisted or Implant-Based Breast Reconstruction Alone.

T. Reimer, B. Gerber, M. Dieterich, 2015, Aesthetic plastic surgery.

Mass Spectrometric Characterization of Protein Structure Details Refines the Proteome Signature for Invasive Ductal Breast Carcinoma

M. Glocker, M. Hecker, T. Reimer, 2011, Journal of the American Society for Mass Spectrometry.

Pain management after cesarean: a randomized controlled trial of oxycodone versus intravenous piritramide

G. Kundt, B. Gerber, M. Dieterich, 2012, Archives of Gynecology and Obstetrics.

Surgical Outcome after Neoadjuvant Chemotherapy and Bevacizumab: Results from the GeparQuinto Study (GBG 44)

M. Rezai, P. Fasching, H. Tesch, 2014, Annals of Surgical Oncology.

Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.

Tanja Fehm, Carsten Denkert, Peter A Fasching, 2012, The New England journal of medicine.

Medical Prevention of Breast Cancer

B. Gerber, M. Dieterich, J. Stubert, 2014, Breast Care.

Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.

U. Jeschke, K. Friese, C. Kuhn, 2007, Anticancer research.

Desmopressin-induced Moschcowitz-like syndrome after treatment of uterine atonic bleeding in a 28-year-old pregnant woman: case report and overview of the literature

T. Reimer, B. Gerber, M. Dieterich, 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Perioperative Screening for Metastatic Disease is not Indicated in Patients with Primary Breast Cancer and no Clinical Signs of Tumor Spread

G. Kundt, T. Reimer, K. Friese, 2004, Breast Cancer Research and Treatment.

Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread.

G. Kundt, T. Reimer, K. Friese, 2003, Breast cancer research and treatment.

Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma

P. Fasching, C. Denkert, S. Loibl, 2014, Breast Cancer Research and Treatment.

A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)

F. Marmé, S. Loibl, V. Nekljudova, 2019, Anti-cancer drugs.

NOTES—case report of a unidirectional flexible appendectomy

B. Gerber, K. Ludwig, J. Bernhardt, 2008, International Journal of Colorectal Disease.

Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy.

A. Schneeweiss, C. Denkert, F. Marmé, 2016, European journal of cancer.

Original Article Toponostics of invasive ductal breast carcinoma: combina- tion of spatial protein expression imaging and quantitative proteome signature analysis

M. Glocker, T. Reimer, H. Thiesen, 2011 .

Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor?

S. Braun, H. Sommer, K. Friese, 2005, Journal of Cancer Research and Clinical Oncology.

Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.

J. Blohmer, G. von Minckwitz, C. Jackisch, 2002, Clinical breast cancer.

The 70-Gene Signature as Prognostic Factor for Elderly Women with Hormone Receptor-Positive, HER2-Negative Breast Cancer

T. Reimer, B. Gerber, D. Elling, 2012, Breast Care.

Predictive Biomarkers and Personalized Medicine Ki67Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

P. Fasching, T. Fehm, R. Thomas, 2013 .

Ki 67 measured after neoadjuvant chemotherapy for primary breast cancer

P. Fasching, T. Fehm, C. Denkert, 2013 .

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

H Tesch, S Loibl, C Denkert, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapry in 686 triple-negative primary breast cancers: Seconday endpoint analysis of the GeparQuinto study (GBG 44).

M. Rezai, P. Fasching, R. Kreienberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract S4-6: Neoadjuvant Chemotherapy with or without Bevacizumab: Primary Efficacy Endpoint Analysis of the GEPARQUINTO Study (GBG 44)

M. Rezai, P. Fasching, T. Fehm, 2010 .

Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.

S. Loibl, S. Kümmel, G. von Minckwitz, 2008, Journal of the National Cancer Institute.

Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.

M. Rezai, P. Fasching, T. Kühn, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).

W. Eiermann, W. Jonat, G. von Minckwitz, 2006, European journal of cancer.

In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.

I. Zuna, J. Blohmer, G. von Minckwitz, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Patient-Reported Outcomes in Implant-Based Breast Reconstruction Alone or in Combination with a Titanium-Coated Polypropylene Mesh – A Detailed Analysis of the BREAST-Q and Overview of the Literature

T. Reimer, B. Gerber, M. Dieterich, 2015, Geburtshilfe und Frauenheilkunde.

Biocompatibility, cell growth and clinical relevance of synthetic meshes and biological matrixes for internal support in implant-based breast reconstruction

T. Reimer, B. Gerber, M. Dieterich, 2015, Archives of Gynecology and Obstetrics.

Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.

U. Jeschke, K. Friese, B. Gerber, 2005, Anticancer research.

Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression?

T. Dimpfl, H. Sommer, K. Friese, 2003, Breast Cancer Research and Treatment.

Risk Factors of Preterm Birth in Women After Local Treatment of Cervical Intraepithelial Neoplasia – a Retrospective Cohort Study

B. Gerber, J. Stubert, E. Mann, 2022, Geburtshilfe und Frauenheilkunde.

Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy.

T. Reimer, B. Gerber, A. Stachs, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022

M. Lux, P. Fasching, T. Fehm, 2022, Geburtshilfe und Frauenheilkunde.

Abstract OT3-01-01: Feasibility of carbon tattooing for targeted lymph node biopsy in breast cancer patients treated by primary systemic therapy (TATTOO trial)

T. Kühn, T. Reimer, B. Gerber, 2020 .

Bilateral Breast Enlargement and Reddish Skin Macules as First Signs of Acute Lymphoblastic T Cell Leukemia

B. Gerber, M. Freund, J. Stubert, 2011, Oncology Research and Treatment.

[Juvenile gigantomastia. Case report and literature survey].

K. Friese, W. Janni, E. Lochmüller, 2004, Zentralblatt fur Gynakologie.

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019

M. Lux, P. Fasching, T. Fehm, 2019, Breast Care.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

M. Lux, M. Beckmann, P. Fasching, 2018, Geburtshilfe und Frauenheilkunde.

Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.

S. Loibl, S. Kümmel, G. von Minckwitz, 2008, Journal of the National Cancer Institute.

Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial

A. Schneeweiss, C. Denkert, S. Loibl, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Abstract S1-11: Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)

P. Fasching, C. Perou, J. Bergh, 2012 .

Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.

Peter A Fasching, Mahdi Rezai, Keyur Mehta, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?

T. Reimer, B. Gerber, M. Dieterich, 2011, Breast Cancer Research and Treatment.

Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).

M. Rezai, P. Fasching, R. Kreienberg, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.

P. Fasching, F. Couch, A. Schneeweiss, 2021, European journal of cancer.

Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials.

P. Fasching, A. Schneeweiss, C. Denkert, 2020, European journal of cancer.

Two different entities of spontaneous ovarian hyperstimulation in a woman with FSH receptor mutation.

T. Reimer, S. Costagliola, B. Gerber, 2010, Reproductive biomedicine online.

Abstract 4699: Responsecharacteristics and overall survival of 781 patients with triple-negativebreast cancer - a meta-analysis on 7 German neoadjuvant studies.

A. Schneeweiss, C. Denkert, S. Loibl, 2013 .

Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group.

J. Blohmer, G. von Minckwitz, C. Jackisch, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract GS4-01: Pooled analysis of five randomized trials investigating temporary ovarian suppression with gonadotropin-releasing hormone analogs during chemotherapy as a strategy to preserve ovarian function and fertility in premenopausal early breast cancer patients

S. Loibl, J. Unger, M. Ceppi, 2018 .

Abstract GS3-05: Survival analysis of the prospectively randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy with weekly nab-paclitaxel with solvent-based paclitaxel followed by anthracycline/cyclophosphamide for patients with early breast cancer – GBG69

P. Fasching, A. Schneeweiss, C. Denkert, 2018 .

The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence

S. Braun, H. Sommer, K. Pantel, 2005, Cancer.

Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study

Carsten Denkert, Stephan Wienert, Frederick Klauschen, 2014, Clinical Cancer Research.

Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane–Anthracycline Containing Chemotherapy—DAFNE (GBG-70)

A. Schneeweiss, C. Denkert, S. Loibl, 2015, Clinical Cancer Research.

Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials

A. Schneeweiss, C. Denkert, S. Loibl, 2015, Breast Cancer Research and Treatment.

Distinct Ezrin Truncations Differentiate Metastases in Sentinel Lymph Nodes from Unaffected Lymph Node Tissues, from Primary Breast Tumors, and from Healthy Glandular Breast Tissues

M. Glocker, T. Reimer, B. Gerber, 2017, Translational oncology.

Unexpected metastatic lobular carcinoma of the breast with intraabdominal spread and subsequent port-site metastasis after diagnostic laparoscopy for exclusion of ovarian cancer.

K. Friese, W. Janni, B. Gerber, 2004, Gynecologic oncology.

Laparoscopic Gastrectomy and Personal Genomics : High-Volume Surgeons and Predictive Biomedicine May Govern the Future for Resectable Gastric Cancer

T. Reimer, B. Gerber, A. Krause, 2009 .

A study of second-look laparoscopy after acute salpingitis

B. Gerber, A. Krause, 1996, Archives of Gynecology and Obstetrics.

Breast Cancer: Is Nipple Sparing Mastectomy Safe?

G. Kundt, T. Reimer, B. Gerber, 2009 .

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019

M. Lux, P. Fasching, T. Fehm, 2019, Breast Care.

Isoflavones – Mechanism of Action and Impact on Breast Cancer Risk

B. Gerber, J. Stubert, 2009, Breast Care.

Prediction of recurrent gestational diabetes mellitus: a retrospective cohort study

B. Gerber, J. Stubert, Stephan Hahn, 2023, Archives of Gynecology and Obstetrics.

Accuracy of Tumor Sizing in Breast Cancer: A Comparison of Strain Elastography, 3-D Ultrasound and Conventional B-Mode Ultrasound with and without Compound Imaging.

B. Gerber, Ä. Glass, A. Stachs, 2016, Ultrasound in medicine & biology.

SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study

T. Reimer, H. Thiesen, D. Koczan, 2016, BMC Cancer.

Primary Systemic Treatment and Oncoplastic Breast Surgery – Influences and Principles

J. Blohmer, S. Kümmel, S. Costa, 2007, Breast Care.

Pregnancy-Associated Breast Cancer – Special Features in Diagnosis and Treatment

I. Bauerfeind, H. Sommer, K. Friese, 2006, Oncology Research and Treatment.

The effects of different lignans and isoflavones, tested as aglycones and glycosides, on hormone receptor-positive and -negative breast carcinoma cells in vitro

B. Gerber, V. Briese, D. Richter, 2011, Archives of Gynecology and Obstetrics.

Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.

U. Jeschke, K. Friese, W. Janni, 2005, Oncology reports.

Quality-of-Life Considerations in the Treatment of Early-Stage Breast Cancer in the Elderly

T. Reimer, B. Gerber, 2010, Drugs & aging.

Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer

M. Golatta, T. Kühn, S. Loibl, 2022, EClinicalMedicine.

Breast Cancer in Special Situations

B. Gerber, 2008, Breast Care.

Surgical Procedures After Neoadjuvant Chemotherapy in Operable Breast Cancer: Results of the GEPARDUO Trial

S. Loibl, J. Blohmer, C. Jackisch, 2006, Annals of Surgical Oncology.

Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44).

M. Rezai, P. Fasching, T. Fehm, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data.

H. Tesch, S. Loibl, J. Blohmer, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mesencephalic Human Neural Progenitor Cells Transplanted into the Adult Hemiparkinsonian Rat Striatum Lack Dopaminergic Differentiation but Improve Motor Behavior

Andreas Wree, Oliver Schmitt, Marine Hovakimyan, 2008, Cells Tissues Organs.

[Responsibility for patient education and incidence of homologous blood transfusions in unilateral breast cancer operations].

B. Gerber, A. Krause, M. Arndt, 1995, Geburtshilfe und Frauenheilkunde.

Differentiating Between Malignant and Benign Breast Masses: Factors Limiting Sonoelastographic Strain Ratio

T. Reimer, B. Gerber, B Gerber, 2012, Ultraschall in der Medizin.

[Detection of atypical site of "sentinel lymph nodes" by lymph drainage scintigraphy in patients with breast carcinoma].

T. Reimer, K. Friese, C. Schümichen, 2000, Zentralblatt fur Gynakologie.

Accuracy of axillary ultrasound in preoperative nodal staging of breast cancer - size of metastases as limiting factor

T. Reimer, B. Gerber, M. Dieterich, 2013, SpringerPlus.

Initial Treatment of Patients with Primary Breast Cancer : Evidence , Controversies , Consensus Spectrum of Opinion of German Specialists at the 15 th International

P. Fasching, T. Fehm, A. Schneeweiss, 2017 .

Abstract S5-05: Postneoadjuvant treatment with zoledronate in patients with tumor residuals after anthracyclines-taxane-based chemotherapy for primary breast cancer – The phase III NATAN study (GBG 36/ABCSG XX)

M. Rezai, P. Fasching, A. Schneeweiss, 2013 .

Abstract P1-09-02: Homologous repair deficiency (HRD) as measure to predict the effect of carboplatin on survival in the neoadjuvant phase II trial GeparSixto in triple-negative early breast cancer

M. Rezai, P. Fasching, A. Schneeweiss, 2017 .

Abstract S5-06: BRCA mutations, therapy response and prognosis in the neoadjuvant GeparQuinto study

M. Rezai, P. Fasching, F. Couch, 2016 .

Current Issues in the Diagnosis and Treatment of Endometrial Carcinoma

B. Gerber, J. Stubert, 2016, Geburtshilfe und Frauenheilkunde.

Primary endpoint analysis of the GEPARDUO study: Comparing dose-dense with sequential adriamycin/docetaxel combination as preoperative chemotherapy (PCHT) in operable breast cancer (T2-3, N0-2, M0)

J. Blohmer, M. Kaufmann, B. Gerber, 2003 .

[Evidence-based recommendations on primary treatment of carcinomas of the breast].

H. Junkermann, N. Harbeck, M. Untch, 2002, Zentralblatt fur Gynakologie.

Prognostic value of Ca 125 levels during primary therapy.

B. Gerber, S. Markmann, V. Briese, 2007, Anticancer research.

Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases

T. Dimpfl, H. Sommer, K. Friese, 2003, Journal of Cancer Research and Clinical Oncology.

[Adjuvant endocrine treatment of breast cancer beyond St. Gallen 2003].

B. Gerber, 2003, Zentralblatt für Gynäkologie.

Expression of the pantumour Thomsen-Friedenreich antigen in the human placenta with the diagnosis of hydatidiform mole.

U. Jeschke, B. Gerber, J. Makovitzky, 2007, Anticancer research.

Prevalence, Clinical Significance and Risk Factors for Developing Scar Pain and Sensibility Disorders in Breast Cancer Patients after Breast-Conserving Therapy and Mastectomy

T. Reimer, B. Gerber, M. Dieterich, 2020, Breast Care.

Comparison of neoadjuvant 6 vs 8 cycles of docetaxel/doxorubicin/cyclophosphamide (TAC) in patients early responding to TACx2-the GEPARTRIO Study.

J. Blohmer, G. von Minckwitz, J. Huober, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

How Important is the Axillary Nodal Status for Adjuvant Treatment Decisions at a Breast Cancer Multidisciplinary Tumor Board? A Survival Analysis

T. Reimer, R. Fietkau, B. Gerber, 2007, Annals of Surgical Oncology.

Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer)

M. Beckmann, A. Schneeweiss, D. Wallwiener, 2009, Breast Care.

Differentiation of HELLP patients from healthy pregnant women by proteome analysis--on the way towards a clinical marker set.

M. Glocker, M. Kreutzer, B. Gerber, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[Quality of life in relation to patient education regarding surgical procedures in primary breast carcinoma].

B. Gerber, A. Krause, 1997, Zentralblatt fur Gynakologie.

Prediction of Spontaneous Preterm Birth in At-risk Women Using Thrombospondin 1 from Cervicovaginal Fluid: A Prospective Observational Study

B. Gerber, M. Dieterich, J. Stubert, 2021, Geburtshilfe und Frauenheilkunde.

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

T. Reimer, B. Gerber, 2009, New England Journal of Medicine.

Breast cancer, locally advanced and metastatic

L. Holmberg, O. Nanni, S. Barni, 2012 .

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022

M. Lux, P. Fasching, T. Fehm, 2022, Breast Care.

[Rating of transvaginal sonography in the evaluation of postmenopausal bleeding].

T. Reimer, K. Friese, B. Gerber, 1999, Zentralblatt für Gynäkologie.

Locoregional recurrence (LRR) after neoadjuvant chemotherapy (NAC): Pooled-analysis results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC).

J. Costantino, C. Geyer, N. Wolmark, 2014, Journal of Clinical Oncology.

Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).

P. Fasching, A. Schneeweiss, C. Denkert, 2017, European journal of cancer.

Abstract P5-16-03: Peripheral sensory neuropathy occurrence and resolution: Results from the neoadjuvant randomized GeparSepto study (GBG 69)

A. Schneeweiss, C. Denkert, S. Loibl, 2017 .

Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

M. Beckmann, A. Schneeweiss, D. Wallwiener, 2011, Breast Care.

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023

P. Fasching, T. Kühn, T. Park-Simon, 2023, Breast Care.

Options for Breast Cancer Prevention in Healthy Women

B. Gerber, 2014, Breast Care.

AGO Recommendations for the Diagnosis and Therapy of Breast Cancer

M. Rezai, A. Schneeweiss, K. Friedrichs, 2007, Breast Care.

13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).

M. Beckmann, T. Fehm, A. Schneeweiss, 2013, Breast care.

Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study

C. Denkert, M. Dietel, S. Wienert, 2014, Clinical Cancer Research.

Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

P. Fasching, T. Fehm, C. Denkert, 2013, Clinical Cancer Research.

Treatment of Ipsilateral Breast Cancer Recurrence (IBCR) after Breast Conservation Therapy (BCT) Therapie des ipsilateralen in-Brust-Rezidivs (IBR) nach brusterhaltender Therapie (BET)

B. Gerber, A. Stachs, S. Hartmann, 2021, Senologie - Zeitschrift für Mammadiagnostik und -therapie.